Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
1 clinical trials · Condition
◉ Watch Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
| Record | Firm | Date |
|---|---|---|
| Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes (NCT03602638) | Chinese PLA General Hospital | 2018-10-01 |
Track Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1 automatically
Every clearance here is in the API, with alerts when new ones post.